NCT00206609 The Role of Oxygen in the Management of Dyspnoea in Advanced Cancer Status COMPLETED Phase PHASE3
NCT00201539 Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients Status COMPLETED Phase PHASE3
NCT00200096 Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial Status COMPLETED Phase PHASE3
NCT00199836 A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer. Status COMPLETED Phase PHASE1
NCT00199602 Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients Status COMPLETED Phase PHASE3
NCT00198276 Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer Status COMPLETED Phase PHASE4
NCT00193583 Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00193570 Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00184496 Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic Study Status COMPLETED Phase PHASE3
NCT00183742 Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere) Status COMPLETED Phase PHASE1
NCT00181012 Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics Status UNKNOWN Phase PHASE3
NCT00180869 Unmodified Versus Leuko-Reduced Allogeneic Red Blood Cells Transfusion in Cancer Patients Status COMPLETED Phase PHASE3
NCT00179868 C-Reactive Protein as a Predictor of Stem Cell Transplant Complications Status COMPLETED Phase N/A
NCT00179855 Extracorporeal Photopheresis for Acute Graft Versus Host Disease Status COMPLETED Phase PHASE2/PHASE3
NCT00179790 Reduced Intensity Transplant Using Extracorporeal Photopheresis Status COMPLETED Phase PHASE1/PHASE2
NCT00178386 Comparison of Educational Services and Outcomes for Patients Treated for Childhood Cancer Status COMPLETED Phase N/A
NCT00178373 Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer Status COMPLETED Phase PHASE2